1 Introduction

The occurrence of severe disruptive events over the past decades, such as the 9/11 terrorist acts in New York, USA, in 2001 (Bueno-Solano and Cedillo-Campos 2014) and the Tohoku earthquake in Japan in 2011 (Matsuo 2015), have raised the attention of organizations and academics to the existing vulnerability of global supply chains. Such severe disruptions usually imply significant financial and operational losses to various industry sectors across multiple countries (Snyder et al. 2016; Zaman et al. 2016). More recently, the worldwide pandemic of a new coronavirus infection (COVID-19) has caused unexpected disruptions that vary from reducing demand for some firms to increasing it for others (Krammer 2021). Globally, it resulted in uncertainty in getting raw materials, impacting the capability to send and receive goods in time due to shortages and logistics bottlenecks and lack of labor capacity to manufacture products (Ivanov and Das 2020; Zanni 2020).

Expectedly, being the pandemic a health disaster, the healthcare supply chain was one of the most affected sectors. The COVID-19 pandemic has raised significant glitches in the healthcare supply chain (Mirchandani 2020), particularly regarding services involved in the containment of the infection and those related to preventive care (Govindan et al. 2020; Gereffi 2020; Sharma et al. 2020). According to World Health Organization (2020), tough decisions have been made to adequate the demands of timely response to the pandemic with the need to keep the essential health treatments. Such a scenario aggravated the urgency for consistently developing resilience throughout the healthcare supply chain (Rosa et al. 2021). Resilience is the system’s capacity to cope with the implications of risk events that cannot be avoided, returning to its original state or moving to a post-disruption state equivalent to or improved in terms of efficiency (Hosseini et al. 2019). Thus, a resilient healthcare supply chain would address countermeasures that allow it to absorb the impacts of the COVID-19 pandemic, adapt to them and, eventually, at least recover its normal performance (Rosa et al. 2021; Usman et al. 2022).

Among the existing countermeasures, the digital transformation promoted by the Fourth Industrial Revolution (a.k.a. Industry 4.0) has been claimed as an effective way to foster supply chain resilience (Ivanov et al. 2019; Ivanov and Dolgui 2020). Because traditional supply chain management practices may be very basic to address the complexities of supply chain risk interactions (Pettit et al. 2019), the integration of new technologies from Industry 4.0 can help maintain (or even improve) supply chain performance in disruptive scenarios (Cavalcante et al. 2019). A few empirical studies (e.g., Ralston and Blackhurst, 2020; Narayanamurthy and Tortorella, 2021) have already indicated the benefits of Industry 4.0 adoption to cope with disruptions, such as the pandemic. Industry 4.0 technologies can support more assertive forecasting and identification of phenomena, assuring a proactive and more responsive supply chain (Frederico et al. 2020). Thus, Industry 4.0 technologies enable supply chain agents to cope more effectively with disruptions, thereby minimizing their undesired implications (Shao et al., 2020).

Nevertheless, the digital transformation of supply chains is still in its early stages (Queiroz and Telles 2018; Shao et al., 2020; Awan et al., 2022; Shaheen et al., 2022), particularly the healthcare supply chain. Additionally, evidence on the contribution of Industry 4.0 integration to the resilience of the healthcare supply chain is scarce (Tortorella et al. 2021a, b, c), impairing the achievement of a comprehensive understanding of the topic and characterizing a theoretical gap in the literature. Against this backdrop, two research questions (RQs) emerge:

RQ 1

What is the impact of Industry 4.0 adoption on the development of resilience throughout the entire healthcare supply chain during the COVID-19 outbreak?

RQ 2

What is the role of resilience development in the relationship between Industry 4.0 adoption and healthcare supply chain performance during the COVID-19 outbreak?

To address those RQs, this research investigates the mediating role of resilience abilities on the relationship between Industry 4.0 technologies adoption and healthcare supply chain performance during the COVID-19 pandemic. 179 practitioners from organizations at multiple tiers of the healthcare supply chain (e.g., manufacturers, distributors, and care providers) in countries severely affected by the pandemic, such as Brazil and India, were surveyed. Multivariate data analysis was adopted to verify the validity of our hypotheses. This research is grounded on concepts from the resource dependence theory, which states that the external resources of organizations affect their behavior (Pfeffer and Salancik 1978). This theory has been used to frame many studies on supply chain management (e.g., Lavassani and Movahedi 2010; Sarkis et al., 2011; Manzouri and Rahman, 2013), justifying its adoption in our research.

The contribution of this research is two-fold. First, in theoretical terms, this study helps bridge the knowledge gap on topics still relatively new to researchers and academics, such as Industry 4.0, resilience development, and implications of the COVID-19 pandemic. Since the pandemic’s beginning, the healthcare supply chain has faced significant challenges that resulted in different strategies to reduce uncertainty and rapidly return to pre-pandemic operational performance (Khan et al. 2021a, b, c; Kumar et al. 2022). The empirical verification of the roles of Industry 4.0 technologies and resilience abilities on the performance of the healthcare supply chain help mitigate the effect of power and uncertainty in the supply chain during disruptive events. Second, from a practical standpoint, this research provides practitioners from the healthcare supply chain arguments to systemically guide and prioritize their digitalization efforts towards a more resilient supply chain. Since both Industry 4.0 adoption and the development of resilience abilities demand great efforts (Sriyanto et al. 2021; Khan et al. 2022a, b), the sooner the healthcare supply chain collaboratively addresses these initiatives, the more prepared it will be to cope with future disruptive events. Although digitalization of the healthcare supply chain does improve its performance, our research indicated that its impact could be significantly enhanced when resilience abilities are concurrently developed, particularly in the Indian and Brazilian contexts.

The remaining of this paper is structured as follows. Section 2 provides the background on the main concepts discussed in this research. Based on such concepts, Sect. 3 formulates the hypotheses investigated. Section 4 describes the research method, whose results are presented and discussed in Sect. 5. Section 6 concludes the paper and offers future research opportunities.

2 Background

This section offers the theoretical background on the topics that form the fundamental concepts approached in our study. Hence, it is divided into five different and interrelated sections to properly present the body of knowledge on (i) Industry 4.0 and supply chain management, (ii) resilient supply chain, (iii) Industry 4.0 and healthcare, (iv) the healthcare supply chain, and (v) resource dependence theory.

2.1 Industry 4.0 and Supply Chain management

The integration of Industry 4.0 technologies into supply chain management has allowed higher interconnectivity between businesses, extending from an isolated, local, and single-company adoption to a supply chain-comprehensive application (Wu et al. 2016). In other words, digital transformation has forced supply chain management to evolve from a linear model to a more integrated one in which data moves in several directions (Ivanov and Dolgui 2020). That has promoted an intense collection of data, communication in real-time among tiers, smart decision-making, and effective and adaptive processes (Shao et al., 2020).

Many researchers have developed guidelines to properly incorporate Industry 4.0 technologies into supply chains. For instance, Shao et al. (2020) proposed four implementation stages: (i) visualization, (ii) first-level linkage, (iii) connected supply chain, and (iv) smart supply chain. Similarly, Frederico et al. (2020) presented a framework for integrating Industry 4.0 into supply chains that encompasses 21 dimensions categorized into four main constructs: (i) managerial and capability supporters, (ii) technology levers, (iii) processes performance requirements, and (iv) strategic outcomes. Queiroz et al. (2019) developed a framework comprised of seven supply chain capabilities supported by six Industry 4.0 technologies: big data analytics, blockchain, artificial intelligence, cloud computing, cyber-physical systems, and the Internet-of-Things (IoT). Despite certain specificities, studies were usually grounded on a common set of technologies with diversified applications. Table 1 synthesizes frequently reported technologies in Industry 4.0 and supply chain management literature.

Table 1 Main technologies applied in resilient supply chains

2.2 Resilient supply chain

Resilience in the supply chain refers to the ability to restore the operational condition (or an improved one) within a reasonable period after disruptive events (Brandon-Jones et al. 2014). Coping with unplanned disruptions is a characteristic of resilient supply chains (Krause et al. 2009) accomplished by continuous control of the context in which the supply chain is inserted so that it can anticipate and adapt accordingly (Ambulkar et al. 2015), yielding the expected performance (Dolgui et al. 2020). The development of supply chain resilience has been fostered through different mechanisms, such as reinforcing vertical and horizontal collaboration in the supply chain, purchasing from redundant suppliers, ensuring capacity slack, determining a demand pool, balancing the import and export of goods, and considering the trade-offs between vertical integration and outsourcing (Tang 2006; Pettit et al. 2010; Wieland and Wallenburg 2013; Scholten and Schilder 2015; Gu et al. 2020).

Despite the apparent consensus on the meaning of resilience in supply chains, information on its formative components is somewhat sparse due to the overlaps in the concepts. In general, the components detail the readiness, response, and restorative abilities necessary to supply chain resilience (Jüttner and Maklan 2011; Hollnagel 2014, 2017), for instance, suggested four interrelated abilities of resilient systems (i.e., monitor, anticipate, respond, and learn), while Briano et al. (2009) complemented them with flexibility, velocity, visibility, and collaboration. Hosseini et al. (2019) built on Biringer et al.‘s (2013) work to conceptualize three supply chain resilience capabilities: absorptive, adaptive, and restorative. Despite the variety of terminologies, the inherent abilities of supply chain resilience are relatively intuitive, and eight main abilities were consolidated in Table 2, providing a conceptual basis for our study.

Table 2 Consolidated abilities of resilient supply chains

2.3 Industry 4.0 and healthcare

The application of Industry 4.0 technologies into healthcare seeks to provide customized care in real-time, moving hospitals to organizations centered on patients, whose departments actively engage towards the achievement of the best health service (Sannino et al. 2018; Tortorella et al. 2020a; Massaro 2021). Industry 4.0 technologies (e.g., cloud computing, IoT, and big data) have been combined and integrated into healthcare treatments and processes so that healthcare systems can monitor, track and store records from patients for better care (Elhoseny et al. 2018; Wu et al. 2018; Khodadad-Saryazdi 2021). Such integration has also been denoted Healthcare 4.0 (H4.0) (Thuemmler and Bai, 2017).

Motivated by the digitalization frenzy from the Fourth Industrial Revolution, researchers’ interest in Healthcare 4.0 has increased over the last few years, leading them to explore the topic from complementary perspectives and at different levels. In terms of health treatments, most studies applied Healthcare 4.0 to measure and control vital parameters of patients, such as body fat (Kim and Choi 2016), physiological biometrics (Hamidi 2019), heartbeat rate (Jeong et al. 2016), and blood pressure (Wan et al. 2018). When considering administrative processes, a similar set of technologies has been introduced into the management of diseases and drugs (Elhoseny et al. 2018) and clinical factors (Garai et al. 2017), evidencing the versatility of Healthcare 4.0 implementation. At an organizational level, Tortorella et al. (2020b) examined the effects of contextual factors on the overall adoption of H4.0. Rosa et al. (2021) studied the association between Healthcare 4.0 adoption and the achievement of resilience in healthcare.

As the principles and technologies from Industry 4.0 are increasingly extended to Healthcare 4.0, new challenges and benefits also emerge for its full implementation. Regarding challenges, Tortorella et al. (2020c) indicated that understanding the implications of social (e.g., misalignment with hospital’s strategy) and technical (e.g., information security risks) barriers are equally relevant. Pan et al. (2019) corroborated this by stating that Healthcare 4.0 adoption might find resistance from physicians, who often see automated systems for clinical decision-making as their substitutes. Concerning benefits, Pramanik et al. (2017) argued that Healthcare 4.0 promotes innovative and transforming health services, reducing their costs (Tortorella et al. 2020d) and increasing the effectiveness of internal and cross-hospital processes (Alloghani et al. 2018). Overall, integrating Industry 4.0 into healthcare treatments is claimed to positively impact hospitals’ performance in the short term. In addition, Industry 4.0 incorporation into administrative processes might influence performance in the longer term (Das et al. 2011).

2.4 The healthcare supply chain

Health systems are conceptualized as all organizations, people, and actions that primarily aim to foster, recover or provide health, including, for instance, a mother taking care of a sick son (World Health Organization, 2007). The concept of a health system also encompasses the interrelationships throughout the healthcare supply chain, focusing on improving health, equity, and responsiveness to legitimate expectations (White 2015). Such a concept reinforces the need for systemically addressing improvement opportunities throughout the healthcare supply chain (Rosa et al. 2021; Tortorella et al. 2021a), as materials represent between 25% and 30% of a hospital’s cost (Roark 2005).

The healthcare supply chain is denoted by its intricacies, resulting from the various utilized supplies and the numerous distribution channels (Borges et al. 2019). The structure of the healthcare supply chain might change depending on the emphasis given by researchers. For instance, Haszlinna Mustaffa and Potter (2009), and Matthew et al. (2013) divided the healthcare supply chain into: (i) manufacturers, which involve the manufacturing of medical equipment, materials, and goods for health treatment; (ii) distributors, who manage the logistics of those items; (iii) wholesalers, who consolidate the items and sell them in large quantities at lower prices; and (iv) caregivers, such as hospitals and medical clinics, that use the items to treat patients. Kritchanchai (2014) considered the tier levels above and added another, denoted as payers, represented by government, patients, and employers. However, because most hospitals need to handle their own supplies and patients at each unit, healthcare supply chains may also be viewed as external or internal. The external supply chain includes negotiation, purchasing and logistics of supplies, and technical assistance and maintenance (Rakovska and Stratieva 2018). The internal supply chain consists of storing, consolidating, distributing, and managing these supplies (Moons et al. 2019).

The healthcare supply chain deals with various challenges inherent to the sector (Ageron et al. 2018). First, the constant technological advances result in shorter product life cycles and higher costs of medical items. Second, it is challenging to predict patients’ frequency and duration of care and primary diagnoses (McKone-Sweet et al. 2005). Further, the unstandardized nomenclature and coding of goods create confusion and misguidance in the sector. Low supply chain orientation and scarcity of capital to establish an adequate infrastructure for information technologies are also barriers to higher efficiency (Mathur et al. 2018). Finally, agents usually operate solely in their own best interests, which significantly limits the development of the healthcare supply chain (Yanamandra 2018). The impact of those challenges is even greater when considering the occurrence of disruptions (Aldrighetti et al. 2019), which motivates the development of resilience in healthcare settings (Tortorella et al. 2021b). In this sense, adopting an adequate theoretical lens may support understanding the intricacies of the healthcare supply chain and its challenges for developing resilience and digitizing while coping with COVID-19 implications. The resource dependence theory is adopted in our study due to the suitability of its concepts and assumptions to the investigated phenomenon.

2.5 Resource dependence theory

Since the seminal proposition by Pfeffer and Salancik in 1978, resource dependence has been deemed an important theory in organizational and strategic management (Hillman et al. 2009). It assumes that organizations are open systems dependent on exogenous contingencies, although managers can mitigate such environmental uncertainty and dependence (Pfeffer and Salancik 1978). In this sense, organizations are expected to develop countermeasures to reduce others’ influence while simultaneously enhancing their own influence capability (Ulrich and Barney 1984). Thus, resource dependence theory provides the fundamental arguments for understanding inter-organizational relationships, indicating that organizations are not autonomous but limited by a network of interdependencies (Biermann and Harsch 2017). Such interdependencies affect both inter-organizational and intra-organizational power, yielding changes in organizational behavior (Drees and Heugens 2013).

Due to its generalizability, resource dependence theory has been widely used to frame studies on supply chain management, as pointed out in a literature review by Lavassani and Movahedi 2010. In another literature review, Sarkis et al. (2011) focused on green supply chain management and identified concepts from resource dependence theory in most studies surveyed. Similarly, Manzouri and Rahman (2013) investigated lean supply chain management studies and classified five lean principles according to the resource dependence theory. More recently, Kim et al. (2020) used the theory’s assumptions to identify three antecedents of logistics integration: trust, commitment, and satisfaction. Overall, the versatility and pervasiveness of resource dependence theory concepts have supported the advance of the body of knowledge on supply chain management. As the development of resilience and digitalization of the healthcare supply chain are relatively recent topics, we anchored our study on this theory to empirically verify and better understand the underlying relationships.

3 Hypotheses development

The adoption of Industry 4.0 technologies is claimed to improve the supply chain, particularly regarding procurement, production, management of inventory, and trading (Fosso Wamba et al. 2018; Frederico et al. 2020). Such adoption fosters more effective information sharing throughout the supply chain (Factorachian and Kazemi, 2021). Industry 4.0’s effects are evidenced at different supply chain tiers since they allow for precise forecasts and plans, enhance the traceability of supplies, and establish smart warehouses and distribution (Hahn 2020). Such Industry 4.0 contributions have been reported as critical for companies willing to cope with the implications of the pandemic (Narayanamurthy and Tortorella 2021).

Although studies have suggested a positive relationship between Industry 4.0 technologies and healthcare services’ resilience (Rosa et al. 2021; Tortorella et al. 2021a), they solely approached hospitals or medical clinics, neglecting the broader impacts of Industry 4.0 on the resilience of other supply chain agents. Moreover, as Yanamandra (2018) indicated, due to the diversified interests among agents and stakeholders, the contribution of Industry 4.0 technologies might occur differently throughout the healthcare supply chain tiers. Nevertheless, the severe disruptions implied by the COVID-19 outbreak have triggered closer collaboration among the healthcare supply chain agents, whose improvement efforts seemed to align with the same goal (Paché 2020). In addition, the wide geographic distribution of the healthcare supply chain agents, the surge in demand for materials, equipment, and medical products, and the restrictions on social and business interactions to contain the pandemic (Gereffi 2020; Sharma et al. 2020) have framed a scenario in which technologies that favor a more effective communication and information sharing are likely to support a more resilient system.

Based on resource dependence theory (Pfeffer and Salancik 1978), organizations depend on multiple resources (e.g., labor, capital, raw material), making it challenging to develop all-embracing countervailing initiatives. Hence, organizations must deal with the criticality and scarcity principle (Hillman et al. 2009), which pushes them to adopt various balancing strategies in closer collaboration with suppliers, partners, or customers. The healthcare supply chain encompasses various organizations and flows that add a significant amount of complexity for its effective management (Aldrighetti et al. 2019). The performance of such fragmented and complex supply chain can be easily affected by the disruption of a single product or agent. The criticality and scarcity of those resources observed during the pandemic have compelled organizations to collaborate beyond their individual interests, propelling a more resilient healthcare supply chain. Therefore, the ability to cope and adjust to those disruptions supported by the integration of Industry 4.0 technologies is likely to positively affect the healthcare supply chain performance, as conceptually illustrated in Fig. 1. To examine that, we formulate the following hypotheses:

Fig. 1
figure 1

Hypothesized model

H 1

The adoption of Industry 4.0 technologies positively impacts the development of resilience in the entire healthcare supply chain during disruptive events, such as the COVID-19 outbreak.

H 2

The development of resilience abilities positively mediates the relationship between the adoption of Industry 4.0 technologies and the performance of the healthcare supply chain during disruptive events, such as the COVID-19 outbreak.

4 Method

The methodological procedure of our study followed an empirical approach, which is a recommended way of capturing knowledge by directly and/or indirectly observing the phenomenon (Goodwin 2005). Quantifying data based on the perceptions of specifically selected participants is quite frequent and might support the investigation of our research questions. Survey is one of the methods most commonly used to collect empirical evidence, as it usually presents potentially good representativeness and statistical significance, lower costs, and is a standardized instrument for data collection (Montgomery 2013). Therefore, the method conducted in our survey-based research consisted of four main steps: (i) development of instrument and measures; (ii) selection and characterization of sample; (iii) verification of constructs’ validity and reliability; and (iv) data analysis. These steps are described below.

4.1 Development of the instrument and measures

The survey instrument was comprised of four parts (see Appendix). In the first part, we asked respondents about the characteristics of their organizations and themselves to determine the profile of our sample. Then, the adoption level of Industry 4.0 technologies was assessed based on a 5-point scale, in which ‘1’ represented no adoption and ‘5’ indicated full adoption. The nine technologies consolidated in Table 1 were used as measures. Although the adoption of Industry 4.0 may involve other aspects beyond technologies (e.g., system design principles), utilizing the adoption level of new technologies (e.g., IoT, cloud computing, and big data) as a proxy for Industry 4.0 implementation level has been already evidenced in previous studies of similar nature (e.g., Rossini et al., 2019; Tortorella et al., 2020c). In the third part, we gathered data on the development level of the eight resilience abilities listed in Table 2 in the respondents’ organizations. We adopted a 5-point scale, varying from 1 (not developed) to 5 (fully developed). Finally, participants were invited to score the variation in performance in their organizations since the COVID-19 outbreak (i.e., January 2020). Changes in performance are often more easily noticed; hence, utilizing this data as a proxy for performance enhances the validity of answers, particularly when those consist of opinions from middle managers (Tortorella et al. 2019). Further, in designing our survey instrument, we followed the guidelines from Stone (1993) and Boparai et al. (2018), which particularly stated the issues related to very long questionnaires. Based on the works from Akyuz and Erkan (2010) and Guersola et al. (2018) on supply chain performance, we selected four performance indicators (i.e., quality, cost, delivery, and inventory level) that were more likely to be relevant for all tiers and organizations included in the healthcare supply chain. Those indicators were evaluated through a 5-point scale that varied from 1 (significantly worsened) to 5 (significantly improved).

Three experts (two academicians and one practitioner) tested the instrument to evaluate its face and content validity, following recommendations in Kothari (2004). They proposed minor improvements in the terminology of some measures. Common method variance was potentially an issue since we applied psychometric scales to collect perceptions from multiple participants (Huber and Power 1985). To curb that, we designed the questionnaire to ensure the dependent and independent variables were far apart (Podsakoff and Organ 1986). Anonymity and confidentiality of responses were informed upfront. Also, participants were told that there were no correct answers (Podsakoff et al. 2003). Finally, we used Harman’s single-factor test (Malhotra et al. 2006), including all variables, to check whether a single factor represented most of the responses’ variance. Results indicated that the first factor explained 21.56% of the total variance, implying that we could disregard common method bias.

4.2 Selection and characterization of the sample

We used a non-random approach based on five pre-established criteria (Smith 1983). First, respondents should be practitioners from organizations that belong to the healthcare supply chain, such as manufacturers (e.g., pharmaceutical, medical device, surgical or medical equipment), distributors or group purchasing organizations (GPO), and care providers (e.g., hospital, clinic, pharmacy). Second, as our goal was to verify the performance variation of those organizations since the COVID-19 outbreak, we targeted respondents located in countries highly affected by the pandemic. At the time of this research, the three countries with the highest number of infected cases and deaths due to COVID-19 were the USA, India, and Brazil (Worldometer 2021). Two factors drove our choice of restricting data collection to Indian and Brazilian organizations: (i) the American socioeconomic context (developed economy) differs from India and Brazil (emerging economies), which might affect the likelihood of Industry 4.0 adoption (Tortorella et al. 2021d), and (ii) the healthcare systems in Brazil and India share similar challenges and characteristics (Marten et al. 2014), offering a relevant and consistent context for analysis and justifying the sole inclusion of respondents located in both countries. Third, we aimed at participants who were middle managers in their respective organizations. Middle managers are usually in charge of deploying organizational strategies into operational processes and activities, leading the organization’s actual changes (Van Dun et al. 2017). Fourth, all surveyed organizations should already have some digitalization initiatives. Meeting this criterion would ensure a minimum familiarity with Industry 4.0 technologies. Finally, due to its high level of complexity, we involved respondents with diversified backgrounds (i.e., clinician and non-clinician), allowing a more holistic perception of the healthcare supply chain.

Based on the characteristics of the healthcare supply chain, we followed the procedure proposed in previous studies (e.g., Tortorella et al., 2017; 2018; Marodin et al., 2019; Moyano-Fuentes et al., 2019), in which researchers considered the respondents’ organizations as the unit of analysis and analyzed the data controlling for the effect of contextual characteristics, such as firm size and tier level. In this sense, we collected information from selected key informants (i.e., middle managers with different backgrounds working in organizations from the healthcare supply chain undergoing digitalization) who provided perceptions about their own organizations. That ensured a more legitimate opinion.

Data were collected during July 2021. An e-mail with the questionnaire link was sent to potential participants. In total, 687 respondents were initially contacted, from which 179 (26.1% response rate) fully responded to the questionnaire (see Table 3). Most participants were in India (56.2%) and had a non-clinician background (74.3%). A well-balanced sample was obtained regarding the healthcare supply chain tiers; i.e., 27.4% were categorized as manufacturers, 36.9% were distributors, and 35.7% were care providers. Finally, participants were predominantly from organizations with less than 100 employees (42.4%).

Table 3 –Sample characteristics (n = 179)

4.3 Verification of constructsvalidity and reliability

To verify the latent constructs using the questionnaire responses, three Exploratory Factor Analysis (EFA) using Principal Component (PC) extraction were conducted (Fabrigar et al. 1999). EFA is often adopted when no a priori hypothesis on factors or patterns of measured variables is known (Finch and West 1997). A similar approach has been adopted in research of the same nature (e.g., Tortorella et al., 2020c; Narayanamurthy and Tortorella, 2021).

An initial EFA was run using the four operational performance indicators as measures (see Table 4). The first PC resulted in high factor loadings (> 0.45; Hair et al., 2014) for all performance indicators, with an eigenvalue of 2.089 and explaining 52.216% of the total variance of the dataset. Cronbach’s alpha was applied to check the reliability of the construct. High reliability was verified as we obtained an alpha value of 0.821 (i.e., > 0.6; Meyers et al., 2006).

Table 4 EFA to validate the operational performance construct

Another EFA was performed with responses related to the adoption of Industry 4.0 technologies. Using a Varimax rotation, we found two PCs with eigenvalues greater than 1 (3.410 and 2.119, respectively), as displayed in Table 5. We replicated the results via an oblique rotation to check for orthogonality, which led to similar components. The analysis of Cronbach’s alphas indicated high reliability of the constructs, yielding values of 0.811 and 0.788, respectively. Based on the factor loadings for each component, two constructs of technologies emerged and were denominated after their main roles (Aceto et al. 2018). The first component consisted of Industry 4.0 technologies that seek to capture (sense) and communicate data from a patient, equipment, material, or processes, such as wireless sensors, IoT, and cloud computing. Due to their similar purpose, the construct was named ‘Sensing-Communication’ [SENS_COMM] technologies. The second component involved Industry 4.0 technologies that might affect or process data, generating useful information, and controlling systems and mechanisms (Tortorella et al. 2020d). The construct was denoted as ‘Processing-Actuation’ [PROC_ACT] technologies.

Table 5 EFA to validate constructs of Industry 4.0 technologies

Finally, an EFA with varimax rotation was carried out using the collected data on the development level of the eight resilience abilities presented in the questionnaire. We extracted two components with eigenvalues ≥ 1, explaining 60.97% of the responses’ variance (as shown in Table 6). Similar results were found based on an oblique rotation. The values for Cronbach’s alpha for each component were 0.765 and 0.804, indicating the high reliability of both constructs. The first component comprises abilities that help organizations to anticipate actions and monitor the occurrence of potential disruptions. According to Hollnagel (2017), the ability of anticipation consists in “knowing what to expect”, while monitoring refers to “knowing what to focus on so that it does not become a threat in the future”. Therefore, we named this first construct ‘Anticipation and Monitoring’ [ANT_MON] abilities. The second component encompassed abilities that help organizations adapt and recover from disruptive events. Based on Hosseini et al.‘s (2019) indications, we denominated this construct ‘Adaptive and Restorative’ [ADAP_REST] abilities.

Table 6 EFA to validate constructs of resilience abilities

Composite reliability (CR) was assessed. All CR values resulted > 0.7, assuring the constructs’ convergent validity (Hair et al. 2014). Standardized scores for each construct given on a continuous scale were then obtained, and pairwise correlations between constructs were analyzed, with results displayed in Table 7. Positive and negative coefficients were found (p-value < 0.01).

Table 7 Pairwise correlations, Cronbach’s alpha values and composite reliability of analyzed variables

4.4 Data analysis

To analyze the data, we performed a set of Ordinary Least Square (OLS) hierarchical linear regression models. Three main models were tested. Models 1 and 2 regressed the mediating variables (constructs of resilience abilities) on the control (tier level and organization size) and independent (constructs of Industry 4.0 technologies) variables. Both models were also checked with country and respondent’s background as dummy variables. No significant association was found, and results were equal when these variables were removed. Hence, country and respondents’ backgrounds were disregarded to enhance our tests’ degrees of freedom and significance. Model 3 regressed performance variation since the COVID-19 outbreak on the control, independent, and mediating variables.

According to Hair et al. (2014), all variables’ assumptions of normality, linearity, and homoscedasticity were checked. We assessed residuals to verify the normality of the error term distribution. Linearity was examined with scatterplots of dependent and independent variables; evidence of nonlinearity was not found in any partial regression plot. Homoscedasticity was visually examined by plotting standardized residuals versus the predicted values. These verifications underpinned the requirements for an OLS regression analysis.

5 Results and discussion

Table 8 displays the unstandardized \(\widehat{\beta }\) coefficients for the OLS regression analyses, as variables were standardized before running the analyses. The regression models’ variance inflation factors (VIFs) were all < 3.0, indicating that multicollinearity could be disregarded (Hair et al. 2014). Models 1 and 2 tested the effect of [SENS_COMM] and [PROC_ACT] on [ANT_MON] and [ADAP_REST], respectively, which were conceptualized as mediating variables. [PROC_ACT] technologies appear to be positively and significantly associated with the development of both constructs of resilience abilities (\(\widehat{\beta }\) = 0.562; p-value < 0.01; and \(\widehat{\beta }\) = 0.185; p-value < 0.05, respectively). However, [SENS_COMM] technologies seem to be positively associated only with [ADAP_REST] abilities (\(\widehat{\beta }\) = 0.472; p-value < 0.01).

Table 8 Results for OLS regression models (unstandardized \(\widehat{\beta }\) coefficients)

In Model 3, performance variation in organizations from the healthcare supply chain since the COVID-19 outbreak was regressed on the control (Model 3 A), independent (Model 3B), and mediating variables (Model 3 C), which yielded significant models (p-value < 0.05). However, Model 3 C displayed the highest predicting capacity with an adjusted R2 of 0.202, overcoming the prediction capacity of Model 3B. In Model 3 C, both resilience abilities constructs were positively related to performance (\(\widehat{\beta }\) = 0.135; p-value < 0.10; and \(\widehat{\beta }\) = 0.225; p-value < 0.01, respectively). Further, [SENS_COMM] technologies were also found to be significantly associated with performance (\(\widehat{\beta }\) = 0.324; p-value < 0.01), while no significant direct association was found for [PROC_ACT] technologies. None of the contextual characteristics tested in Model 3 C (i.e., tier level and organization size) were significant in explaining performance variation of healthcare supply chain organizations since the beginning of the COVID-19 outbreak.

We now discuss our findings, which partially support our hypotheses, and the relationships empirically validated and displayed in Fig. 2. Concerning the impact of Industry 4.0 technologies on the development of resilience abilities in the healthcare supply chain during the COVID-19 outbreak, our results indicated that [PROC_ACT] technologies positively contribute to both [ANT_MON] and [ADAP_REST] abilities, as proposed in H1. In turn, [SENS_COMM] technologies seem to be positively associated only with [ADAP_REST] abilities. This outcome was particularly surprising in light of the role played by these Industry 4.0 technologies, which comprises the capturing and sharing of the data collected from processes, treatments, products, services, equipment, and patients across the entire healthcare supply chain. Supposedly, a high adoption level of [SENS_COMM] technologies would provide the means to achieve greater awareness of the current situation during the pandemic, facilitating the foresight of additional disruptions and proactive development of necessary countermeasures. Our findings do not validate such assumption. Nevertheless, we found a positive direct effect of [SENS_COMM] technologies on the performance variation of the healthcare supply chain since the COVID-19 outbreak.

Fig. 2
figure 2

Empirically verified relationships

An explanation for the counterintuitive result above may refer to how unprecedented the interruption caused by COVID-19 was. Gereffi (2020) and Govindan et al. (2020) indicated that the COVID-19 pandemic is an unprecedented disruptive event due to its impact and pervasiveness across the globe and its duration. According to WHO (2021), on December 31st, 2019, information on cases of pneumonia of unknown cause in Wuhan City, China, was first reported, and the new coronavirus was identified as the cause by Chinese authorities on January 7th, 2020. Since then, the COVID-19 pandemic has caused millions of deaths, severely impacting communities, businesses, supply chains, and countries up to this day. Such uniqueness may hinder the proper development of anticipation actions, jumping directly to a reactive mode in terms supply chain management.

Moreover, the resource dependence theory states that when the resources an organization needs are scarce, not readily obtainable, or under the control of uncollaborative agents, the resulting unbalanced exchanges lead to distinction in power, authority, and access to such resources (Hillman et al. 2009). This behavior was particularly observed at the beginning of the COVID-19 outbreak, in which organizations, governments, and the healthcare supply chain as a whole were not collaborating as cohesively as nowadays (Friday et al. 2021). That might justify the significant impact of [SENS_COMM] technologies on the performance of the healthcare supply chain and the poor association of these technologies with the [ANT_MON] abilities, partially supporting H2.

Concerning the mediating role of resilience abilities, the [ADAP_REST] abilities appear to significantly and positively mediate the relationship between [SENS_COMM] and [PROC_ACT] technologies and the performance of the healthcare supply chain since the COVID-19 outbreak, as initially envisioned. The prominence of resilience abilities that help to adapt and recover from the COVID-19 disruptions can be partially justified by the unprecedented characteristics of the pandemic, as aforementioned. The concurrent development of those abilities and the high adoption of Industry 4.0 technologies across the healthcare supply chain seem to lead to greater performance improvements and mitigate the negative implications of the pandemic. Such a result may also emerge from the fact that organizations generally determine their strategies to cope with shifts in power relationships with other organizations. According to Archibald (2021), uncertainty clouds resources control, leading to the development of dependence-lessening strategies. As uncertainty and dependencies increase, so does the necessity for close relationships with other agents. Industry 4.0 technologies tend to favor more effective management of the healthcare supply chain, reducing uncertainties, increasing flexibility, and supporting more assertive decisions (Hossain and Thakur 2021). That supports the alignment between internal organizational needs and elements with external pressures and influences from the supply chain, which, together with an increased responsiveness ability, can yield a faster adaptation to the new scenario imposed by the disruptive event (e.g., COVID-19 pandemic) and the maintenance or even improvement of performance.

6 Conclusions

Our research investigated the role of resilience abilities in the relationship between Industry 4.0 technologies adoption and healthcare supply chain performance during the COVID-19 pandemic. We performed a survey with practitioners from organizations of the healthcare supply chain in Brazil and India, framing our hypotheses and discussion on concepts from resource dependence theory. This study connected three emerging topics related to the healthcare supply chain: resilience development, Industry 4.0 adoption, and the COVID-19 disruptions. As discussed next, our findings contribute to both theory and practice on these topics.

6.1 Implications to theory

Our investigation contributed to the state-of-the-art on healthcare supply chain management by bridging the knowledge on topics still relatively new to researchers and academics, such as Industry 4.0, resilience development, and implications from the COVID-19 pandemic. We framed our hypotheses’ development by concepts from the resource dependence theory, also used to discuss our main findings. Since the pandemic’s beginning, organizations in the healthcare supply chain have displayed different behaviors mainly driven by the availability of resources used to fight the pandemic (e.g., materials, labor, and personal protective equipment). That led to strategies to reduce uncertainty in the supply chain (aligned with the resource dependence theory principles) and quickly return to pre-pandemic operational performance, searching for a more resilient operation. We empirically verified that the impact of Industry 4.0 technologies on performance is positively mediated by the development of resilience abilities in the healthcare supply chain, emphasizing the need for an alignment of interests across the healthcare supply chain towards greater effectiveness. Our results contribute to the existing body of knowledge on the resource dependence theory, suggesting that resilience development through digitalization can mitigate the effect of power and uncertainty in the supply chain even during disruptive events. To the best of our knowledge, no similar investigation in the literature has empirically analyzed such relationships in the pandemic scenario and from the healthcare supply chain perspective.

6.2 Contributions to practice

From a practical perspective, our study offers managers and organizations from the healthcare supply chain arguments to achieve higher performance levels based on digitalization and resilience development when disruptive events occur. The COVID-19 pandemic has imposed extreme challenges on the healthcare supply chain worldwide, raising the need to accelerate improvement initiatives, such as digital transformation. Although digitalization of the healthcare supply chain does improve its performance, our research indicated that its impact could be significantly enhanced when resilience abilities are concurrently developed, particularly in the Indian and Brazilian contexts. Such a result is relevant for the organizations embedded in the healthcare supply chain and governments and institutions in charge of developing policies and regulations related to improving healthcare systems in emerging economies.

At the company level, our results should appeal to managers since they translate the well-known four resilient abilities of healthcare systems (i.e., monitor, anticipate, respond, and learn) proposed by Braithwaite et al. (2015) and Hollnagel (2017) in the context of clinical operations to the healthcare supply chain context. Many healthcare organization managers come from a clinical background (Sarto and Veronesi 2016) and are challenged by managerial activities they were not formally trained to perform. Bridging such knowledge gap by establishing connections between activities they are familiar with (e.g., monitoring patients’ signals and anticipating their needs) and supply chain good practices (e.g., maintaining high situational awareness and being financially adept to meet contingencies proactively) should aid in improving their performance and communication with other organization actors.

Our results show the significant positive impact of sensing and communicating (SENS_COMM) technologies on supply chain performance after the COVID-19 outbreak. Within the SENS_COMM factor, wireless sensors stand out with the highest associated loading. Such a result is aligned with the technological improvements observed in healthcare logistics in the past decade. There has been an increase in the use of mobile wireless sensor networks to monitor transport conditions inside containers, particularly in transatlantic cargo vessels, which are exposed to uneven environmental conditions (Becker et al. 2010). The online monitoring of shipments allowed healthcare providers to better control inventories and highlighted the practical importance of efficient communication among supply chain actors, a trend already verified in the literature (VanVactor 2011). New forms of transportation are also being devised to reduce disruptions in healthcare supplies delivery, e.g., the use of drones for small and medium-sized shipments (Jaekel 2021). The practical takeaway of our result for healthcare procurement departments is that suppliers’ delivery speed and cargo remote monitoring capability are key in improving supply chain performance. Since both Industry 4.0 adoption and the development of resilience abilities require great efforts, the sooner the organizations from the healthcare supply chain collaboratively work on those initiatives, the more prepared they will be to cope with future disruptive events.

6.3 Limitations and future research

A few limitations of our study should be highlighted. Initially, we focused on respondents located in emerging economies (i.e., India and Brazil). Although enhancing the replicability of our results to healthcare supply chains located in similar socioeconomic contexts, it also limits the generalization of findings to a broader audience (e.g., developed economies). Another limitation concerning the data collection refers to the performance indicators adopted in our study. Although cost, quality, delivery, and inventory level are widely used in the literature to investigate supply chain performance (e.g., Marodin et al., 2016; 2017; Guersola et al., 2018; Borges et al., 2020), other indicators could complement our analysis. Particularly, the use of the supply chain operations reference (SCOR) model (Supply Chain Council, 2004) could help address this issue. Thus, further research could expand the data collection by performing a multinational study and including other performance metrics, raising complementary indications. Second, we verified the relationships between Industry 4.0 adoption, resilience development, and healthcare supply chain performance under the disruptive scenario caused by the COVID-19 pandemic. Despite its unique relevance, the pandemic disruptions are unique, which somewhat constrains our findings to this disruptive event. Future studies could verify how learnings could be extended to different disruptive events, such as natural disasters and socio-political conflicts. Finally, we remark that the survey-based method adopted here does not support an in-depth analysis of the Industry 4.0 adoption pathways in the healthcare supply chain, which could be a relevant research question for future investigation. Hence, the conduction of multi-case studies could complement our findings, potentially raising new insights into the literature body.

7 Appendix—Applied questionnaire

1- Please, provide below the following information:

(a) The number of employees of your organization:

( ) < 100 employees

( ) between 100 and 250 employees

( ) between 250 and 1,000 employees

( )  > 1,000 employees

(b) Country where your organization is located: ______________________

(c) Your tier of the healthcare supply chain:

( ) Manufacturer (pharmaceutical, medical device, surgical or medical equipment).

( ) Distributor or Group of Purchasing Organization (GPO).

( ) Care provider (hospital, clinic, pharmacies).

(d) Your role in the organization: ______________________

(e) Your academic background: ______________________

2- Please, indicate below the adoption level of the following technologies in your organization:

Scale: from 1 (no adoption) to 5 (fully adopted).

Technology

1

2

3

4

5

Enterprise Resource Planning (ERP)

     

Big data

     

Radio Frequency Identification (RFID)

     

Internet of Things (IoT)

     

Sensors

     

Cloud computing

     

Cyber-physical systems

     

Blockchain

     

Augmented and virtual reality

     

Additive manufacturing

     

Digital twin

     

Machine learning

     

3- Please, indicate below the readiness level of your organization regarding the following abilities:

Scale: from 1 (not developed) to 5 (fully developed).

Abilities

1

2

3

4

5

Learning from experience

     

Financially adept to proactively meet contingencies

     

Always maintain high situational awareness

     

Provide a quick response to SC disruption

     

Cope with changes brought by SC disruption

     

Adapt to SC disruption easily

     

Recovery to normal operations speedily after SC disruption

     

Easy and fast access to knowledge when facing an operational failure

     

4- Please, indicate the evolution of the following performance indicators in your organization since the COVID-19 outbreak (January 2020):

Scale: from 1 (significantly worsened) to 5 (significantly improved).

Performance indicators

1

2

3

4

5

Quality

     

Cost

     

Delivery

     

Inventory level